en

PRODUCT DETAIL

Horime 40 mg /10 mg

Code 0954E
MA number 31/0146/22-S
Product Form: fbl flm 60x40 mg /10 mg (blis.OPA/Al/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 31 - HYPOLIPIDAEMICA
ATC:
C CARDIOVASCULAR SYSTEM
C10 Lipid modifying agents
C10B Lipid modifying agents, combinations
C10BA HMG CoA reduct. inhib in conbinat. w. ot. lip. modifying agents
C10BA06 Rosuvastatin and ezetimibe
Shelf life: 36
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10b fixed combination application
MA issued: 16.06.2022
Validity: 16.06.2027
Pediatric warnings: Yes
PIL: PIL_Horime 40 mg_10 mg_05_2022.pdf  
SPC: SPC_Horime 40 mg_10 mg_05_2022.pdf  
Safety feature Yes
Data update: 21.06.2022
eu-flag.png sk-flag.png